Trial record 1 of 1 for:    NCT01866826
Previous Study | Return to List | Next Study

Rifaximin for Chronic Immune Activation in People With HIV

This study is currently recruiting participants.
Verified July 2013 by National Institutes of Health Clinical Center (CC)
Sponsor:
Collaborators:
University of Pittsburgh Division of Infectious Diseases
Walter Reed Navy MMC
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Cancer Institute (NCI) )
ClinicalTrials.gov Identifier:
NCT01866826
First received: May 29, 2013
Last updated: April 9, 2014
Last verified: July 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 2014
  Estimated Primary Completion Date: October 2014 (Final data collection date for primary outcome measure)